ComGenex Announces Award of Grant Funding for New Nanotechnology Subsidiary
"Our pilot studies have shown very promising results and this grant underlines the relevance of our work in this field," commented Dr. Laszlo Urge, CEO of ComGenex.
Dr. Ferenc Darvas, President of ComGenex and of Thales Nanotechnology added, "Nanoscale technology has a number of benefits for combinatorial chemistry and other chemistry applications. The processes and technology used by Thales have the potential to significantly improve reaction times leading to an increase in efficiency in the synthesis of compound libraries with the benefit of higher purity."
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.